Heart Rhythm Society Releases New Expert Consensus Statement On Lead Management and Extraction

Experts from ten international organizations share first comprehensive clinical guidance on the broad field of lead management

September 15, 2017

Media Contact

Allison Kassel
BRG Communications
akassel@brgcommunications.com
703-739-8362
Shane Osborne
Heart Rhythm Society
media@hrsonline.org
202-464-3431

YOKOHAMA, JAPAN – Today, the Heart Rhythm Society (HRS) issued an international consensus statement that comprehensively addresses lead management for patients with cardiovascular implantable electronic devices (CIEDs). The 2017 HRS Expert Consensus Statement on Cardiovascular Implantable Electronic Device Lead Management and Extraction was presented today at the 10th Asia Pacific Heart Rhythm Society (APHRS) Annual Scientific Session held in conjunction with the Annual Meeting of the Japanese Heart Rhythm Society (JHRS). The expert consensus statement is the first to have a comprehensive discussion of lead management issues, including lead extraction, and is an update to the 2009 HRS lead extraction clinical document .   

It is estimated that 1.2–1.4 million CIEDs are implanted annually worldwide (MedMarket Diligence LLC Report C500), and most use leads that connect the generator to cardiac tissue. Questions on lead management arise in several situations, including when changes in a patient’s clinical condition make a different functionality more or less important, if a lead becomes nonfunctional, and if the presence of a lead is thought to interfere with the patient’s optimal treatment.

The document is intended to help physicians, facilities, and other health care professionals involved in the care of patients with CIEDs in their decision-making process for managing leads. The authors address practical clinical guidance in the broad field of lead management, including extraction. The document includes specific recommendations in the following areas: 

  • Lead Survival
  • Existing CIED Lead Management
  • Indications for Lead Extraction (Infectious)
  • Indications for Lead Extraction (Noninfectious)
  • Outcomes and Follow-up

“Lead management is important now more than ever given the growing number of implanted devices due to worldwide aging demographics, the increased clinical utilization of CIEDs, and the time required for technology development of devices that do not utilize leads,” says Fred M. Kusumoto, MD, FHRS, FACC, director of heart rhythm services at Mayo Clinic, Jacksonville, Florida, and professor at Mayo Clinic School of Medicine. “The new expert consensus statement provides a much-needed single set of recommendations that clinicians from around the world can consult, which will ultimately lead to improved patient care.”

The 29-member expert group, which created the recommendations, included representatives from international professional societies focused on heart rhythm issues and other organizations representing subspecialties such as cardiac surgery, infectious diseases, anesthesiology, and pediatrics. The writing group performed literature searches and developed recommendations based on available data and commonly encountered clinical situations identified by the writing committee. Evidence was assessed by writing committee members, and the recommendations underwent a public comment period, internal review, and external peer review for further consensus.

The writing group notes that registries will be critical to further understand lead management in the setting of infection, lead failure, and changing clinical conditions. International interactions and collaboration on technique and methodology can also further help identify best practices and can contribute to the understanding of clinical outcomes in patients.

The expert consensus statement was developed in collaboration with ten international organizations: Heart Rhythm Society (HRS), American College of Cardiology (ACC), American Heart Association (AHA), Asia Pacific Heart Rhythm Society (APHRS), American Society of Anesthesiologists (ASA), European Heart Rhythm Association (EHRA), Infectious Diseases Society of America (IDSA), Latin American Heart Rhythm Society (LAHRS), Pediatric and Congenital Electrophysiology Society (PACES), and Society of Thoracic Surgeons (STS). 

The statement was published today in the online edition of HeartRhythm , the official journal of the Heart Rhythm Society, and is also posted on the HRS Clinical Guidelines & Documents website. To review the full document, please click here .

About the Heart Rhythm Society

The Heart Rhythm Society is the international leader in science, education and advocacy for cardiac arrhythmia professionals and patients, and the primary information resource on heart rhythm disorders. Its mission is to improve the care of patients by promoting research, education and optimal health care policies and standards. Incorporated in 1979 and based in Washington, DC, it has a membership of more than 5,900 heart rhythm professionals in more than 70 countries around the world. For more information, visit www.HRSonline.org .

About the HeartRhythm Journal

HeartRhythm provides rapid publication of the most important science developments in the field of arrhythmias and cardiovascular electrophysiology (EP). As the official journal of the Heart Rhythm Society, HeartRhythm publishes both basic and clinical subject matter of scientific excellence devoted to the EP of the heart and blood vessels, as well as therapy. The journal is the only EP publication serving the entire electrophysiology community from basic to clinical academic researchers, private practitioners, technicians, industry and trainees. HeartRhythm has an impact factor of 4.866 (as of 2016) and ranks 23rd out of 114 cardiovascular medicine journals worldwide by the Institute for Scientific Information, remaining the number one specialty journal in cardiology. It is also the official publication of the Cardiac Electrophysiology Society.